Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Cutan Ocul Toxicol ; 31(3): 253-7, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22172047

ABSTRACT

A 62-year-old male treated with pegylated interferon α-2b plus ribavirin for chronic hepatitis C complained of sudden painless decreased visual acuity. This patient was diagnosed as having simultaneous occlusions of the branch retinal artery and central retinal vein, although he had no history of major risk factors for retinal vessel (artery and vein) occlusion. Unfortunately, visual acuity did not completely recover. Furthermore, the patient was heterozygous for interleukin (IL) 28B genetic polymorphisms. The etiology of interferon-associated retinal vessel occlusion is not yet clear. However, a review based on previous case reports suggested that some factors including ribavirin might act as a risk or cause of retinal vessel occlusion.


Subject(s)
Hepatitis C, Chronic/drug therapy , Interferon-alpha/adverse effects , Polyethylene Glycols/adverse effects , Retinal Artery Occlusion/chemically induced , Retinal Vein Occlusion/chemically induced , Ribavirin/adverse effects , Adult , Humans , Interferon alpha-2 , Interferon-alpha/therapeutic use , Interferons , Interleukins/genetics , Male , Middle Aged , Polyethylene Glycols/therapeutic use , Polymorphism, Genetic , Recombinant Proteins/adverse effects , Recombinant Proteins/therapeutic use , Retinal Artery Occlusion/physiopathology , Retinal Vein Occlusion/physiopathology , Ribavirin/therapeutic use , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...